Description

Etamzilat (etamsylate) ampoules 12.5% 2 ml. №10

Ingredients

Etamzilat (etamsylate) 12.5% solution

Dosage

The usual dosage is 1-2 ampoules per day, administered intramuscularly or intravenously.

Indications

Etamzilat is indicated for the treatment of acute bleeding episodes in patients with various conditions such as menorrhagia, peptic ulcers, and postoperative bleeding.

Contraindications

Do not use Etamzilat in patients with a known hypersensitivity to the drug or in those with a history of thromboembolic events.

Directions

Administer Etamzilat as directed by a healthcare provider. Follow the recommended dosage and route of administration carefully.

Scientific Evidence

Etamzilat (etamsylate) has been shown to effectively reduce bleeding episodes in various clinical studies. One study published in the Journal of Hematology demonstrated the efficacy of etamsylate in controlling menorrhagia in women of reproductive age. Another study in the Journal of Gastroenterology highlighted its effectiveness in managing bleeding peptic ulcers.

Additional Information

Etamzilat works by enhancing platelet adhesion and aggregation, thereby promoting hemostasis and reducing bleeding. It also helps in stabilizing capillary permeability, which is beneficial in conditions associated with increased vascular fragility.

Compared to other hemostatic agents, Etamzilat has shown comparable efficacy with a favorable safety profile. Its rapid onset of action and ease of administration make it a preferred choice in the management of acute bleeding episodes.